Form: 10-Q

Quarterly report pursuant to Section 13 or 15(d)

November 26, 2024

false --12-31 Q3 0001447380 P24M 0001447380 2024-01-01 2024-09-30 0001447380 2024-11-25 0001447380 2024-09-30 0001447380 2023-12-31 0001447380 us-gaap:RelatedPartyMember 2024-09-30 0001447380 us-gaap:RelatedPartyMember 2023-12-31 0001447380 us-gaap:NonrelatedPartyMember 2024-09-30 0001447380 us-gaap:NonrelatedPartyMember 2023-12-31 0001447380 2024-07-01 2024-09-30 0001447380 2023-07-01 2023-09-30 0001447380 2023-01-01 2023-09-30 0001447380 us-gaap:CommonStockMember 2022-12-31 0001447380 MFON:EquityPayableMember 2022-12-31 0001447380 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001447380 us-gaap:RetainedEarningsMember 2022-12-31 0001447380 2022-12-31 0001447380 us-gaap:CommonStockMember 2023-03-31 0001447380 MFON:EquityPayableMember 2023-03-31 0001447380 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001447380 us-gaap:RetainedEarningsMember 2023-03-31 0001447380 2023-03-31 0001447380 us-gaap:CommonStockMember 2023-06-30 0001447380 MFON:EquityPayableMember 2023-06-30 0001447380 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001447380 us-gaap:RetainedEarningsMember 2023-06-30 0001447380 2023-06-30 0001447380 us-gaap:CommonStockMember 2023-12-31 0001447380 MFON:EquityPayableMember 2023-12-31 0001447380 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0001447380 us-gaap:RetainedEarningsMember 2023-12-31 0001447380 us-gaap:CommonStockMember 2024-03-31 0001447380 MFON:EquityPayableMember 2024-03-31 0001447380 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001447380 us-gaap:RetainedEarningsMember 2024-03-31 0001447380 2024-03-31 0001447380 us-gaap:CommonStockMember 2024-06-30 0001447380 MFON:EquityPayableMember 2024-06-30 0001447380 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0001447380 us-gaap:RetainedEarningsMember 2024-06-30 0001447380 2024-06-30 0001447380 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001447380 MFON:EquityPayableMember 2023-01-01 2023-03-31 0001447380 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001447380 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001447380 2023-01-01 2023-03-31 0001447380 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001447380 MFON:EquityPayableMember 2023-04-01 2023-06-30 0001447380 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001447380 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001447380 2023-04-01 2023-06-30 0001447380 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001447380 MFON:EquityPayableMember 2023-07-01 2023-09-30 0001447380 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001447380 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001447380 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001447380 MFON:EquityPayableMember 2024-01-01 2024-03-31 0001447380 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001447380 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001447380 2024-01-01 2024-03-31 0001447380 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001447380 MFON:EquityPayableMember 2024-04-01 2024-06-30 0001447380 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-04-01 2024-06-30 0001447380 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001447380 2024-04-01 2024-06-30 0001447380 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0001447380 MFON:EquityPayableMember 2024-07-01 2024-09-30 0001447380 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0001447380 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001447380 us-gaap:CommonStockMember 2023-09-30 0001447380 MFON:EquityPayableMember 2023-09-30 0001447380 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001447380 us-gaap:RetainedEarningsMember 2023-09-30 0001447380 2023-09-30 0001447380 us-gaap:CommonStockMember 2024-09-30 0001447380 MFON:EquityPayableMember 2024-09-30 0001447380 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001447380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001447380 us-gaap:RetainedEarningsMember 2024-09-30 0001447380 2023-01-01 2023-12-31 0001447380 srt:MinimumMember 2024-09-30 0001447380 srt:MaximumMember 2024-09-30 0001447380 us-gaap:ComputerSoftwareIntangibleAssetMember 2024-07-01 2024-09-30 0001447380 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-07-01 2023-09-30 0001447380 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember MFON:TwoCustomersMember 2024-01-01 2024-09-30 0001447380 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember MFON:TwoCustomersMember 2023-01-01 2023-09-30 0001447380 us-gaap:IntangibleAssetsAmortizationPeriodMember 2024-01-01 2024-09-30 0001447380 MFON:PatentsAndTrademarksMember 2023-12-31 0001447380 MFON:PatentsAndTrademarksMember 2024-01-01 2024-09-30 0001447380 MFON:PatentsAndTrademarksMember 2024-09-30 0001447380 us-gaap:CustomerRelationshipsMember 2023-12-31 0001447380 us-gaap:CustomerRelationshipsMember 2024-01-01 2024-09-30 0001447380 us-gaap:CustomerRelationshipsMember 2024-09-30 0001447380 us-gaap:TradeNamesMember 2023-12-31 0001447380 us-gaap:TradeNamesMember 2024-01-01 2024-09-30 0001447380 us-gaap:TradeNamesMember 2024-09-30 0001447380 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2024-01-01 2024-09-30 0001447380 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-12-31 0001447380 us-gaap:ComputerSoftwareIntangibleAssetMember 2024-01-01 2024-09-30 0001447380 us-gaap:ComputerSoftwareIntangibleAssetMember 2024-09-30 0001447380 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-01-01 2023-09-30 0001447380 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2024-09-30 0001447380 MFON:LeaseEndingJanuary2027Member 2021-02-01 0001447380 MFON:LeaseEndingJanuary2027Member srt:MinimumMember 2021-02-01 2021-02-01 0001447380 MFON:LeaseEndingJanuary2027Member srt:MaximumMember 2021-02-01 2021-02-01 0001447380 MFON:LeaseEndingJanuary2027Member 2021-02-01 2021-02-01 0001447380 MFON:LeaseEndingJanuary2027Member 2024-09-30 0001447380 2024-03-01 2024-03-01 0001447380 MFON:AcoaNoteMember 2024-01-01 2024-09-30 0001447380 MFON:AcoaNoteMember 2024-09-30 0001447380 MFON:AcoaNoteMember 2023-12-31 0001447380 MFON:RelatedPartySecuredPromissoryNotesMember 2024-01-01 2024-09-30 0001447380 MFON:RelatedPartySecuredPromissoryNotesMember 2024-09-30 0001447380 MFON:RelatedPartySecuredPromissoryNotesMember 2023-12-31 0001447380 MFON:RelatedPartyConvertibleNotesMember 2024-09-30 0001447380 MFON:RelatedPartyConvertibleNotesMember 2023-12-31 0001447380 MFON:RelatedPartyUnsecuredPromissoryNoteMember 2024-01-01 2024-09-30 0001447380 MFON:RelatedPartyUnsecuredPromissoryNoteMember 2024-09-30 0001447380 MFON:RelatedPartyUnsecuredPromissoryNoteMember 2023-12-31 0001447380 us-gaap:ConvertibleDebtMember 2024-09-30 0001447380 us-gaap:ConvertibleDebtMember 2023-12-31 0001447380 MFON:AcoaNoteMember MFON:LivelenzMember 2017-11-06 2017-11-06 0001447380 MFON:AcoaNoteMember MFON:LivelenzMember 2019-11-01 2019-11-01 0001447380 MFON:AcoaNoteMember MFON:LivelenzMember 2021-08-01 2021-08-01 0001447380 MFON:AcoaNoteMember MFON:LivelenzMember 2022-08-01 2022-08-01 0001447380 MFON:AcoaNoteMember MFON:LivelenzMember MFON:RemainingTermOfTheAgreementMember 2024-01-01 2024-09-30 0001447380 MFON:AcoaNoteMember MFON:LivelenzMember 2024-01-01 2024-09-30 0001447380 MFON:CreditAgreementMember srt:DirectorMember 2021-06-30 0001447380 MFON:CreditAgreementMember srt:DirectorMember 2021-06-30 2021-06-30 0001447380 MFON:CreditAgreementMember srt:DirectorMember 2022-06-30 2022-06-30 0001447380 MFON:CreditAgreementMember srt:DirectorMember 2022-11-11 0001447380 MFON:CreditAgreementMember MFON:ThomasAkinMember 2024-01-01 2024-09-30 0001447380 MFON:CreditAgreementMember 2024-01-01 2024-09-30 0001447380 MFON:CreditAgreementMember 2024-09-30 0001447380 MFON:EightConvertibleNotesPayableMember us-gaap:RelatedPartyMember 2023-12-31 0001447380 MFON:EightConvertibleNotesPayableMember us-gaap:RelatedPartyMember 2023-10-01 2023-12-31 0001447380 MFON:EightConvertibleNotesPayableMember 2023-12-31 0001447380 MFON:EightConvertibleNotesPayableMember us-gaap:RelatedPartyMember 2024-03-31 0001447380 MFON:EightConvertibleNotesPayableMember us-gaap:RelatedPartyMember 2024-01-01 2024-03-31 0001447380 MFON:EightConvertibleNotesPayableMember us-gaap:RelatedPartyMember 2024-06-30 0001447380 MFON:EightConvertibleNotesPayableMember us-gaap:RelatedPartyMember 2024-04-01 2024-06-30 0001447380 MFON:EightConvertibleNotesPayableMember us-gaap:RelatedPartyMember 2024-09-30 0001447380 MFON:EightConvertibleNotesPayableMember us-gaap:RelatedPartyMember 2024-07-01 2024-09-30 0001447380 MFON:RelatedPartyConvertibleNoteMember 2024-09-30 0001447380 MFON:RelatedPartyConvertibleNoteMember 2024-01-01 2024-09-30 0001447380 MFON:RelatedPartyConvertibleNoteMember srt:MaximumMember 2024-09-30 0001447380 MFON:UnsecuredPromissoryNotesMember 2021-07-01 0001447380 MFON:UnsecuredPromissoryNotesMember 2021-07-01 2021-07-01 0001447380 MFON:UnsecuredPromissoryNotesMember 2023-01-31 2023-01-31 0001447380 MFON:UnsecuredPromissoryNotesMember 2024-09-30 0001447380 MFON:UnsecuredPromissoryNotesMember 2024-01-01 2024-09-30 0001447380 MFON:TenConvertibleNotesPayableMember 2023-12-31 0001447380 MFON:TenConvertibleNotesPayableMember 2023-10-01 2023-12-31 0001447380 MFON:ConvertibleNoteMember 2024-09-30 0001447380 MFON:ConvertibleNoteMember 2024-01-01 2024-09-30 0001447380 MFON:JohnHarrisMember 2023-01-01 2023-01-31 0001447380 MFON:ConversionOfInterestPayableOnRelatedPartyDebtIntoCommonStockMember MFON:ThomasAkinMember 2023-03-27 2023-03-27 0001447380 MFON:ConversionOfInterestPayableOnRelatedPartyDebtIntoCommonStockMember MFON:ThomasAkinMember 2023-03-27 0001447380 MFON:ConversionOfInterestPayableOnRelatedPartyDebtIntoCommonStockMember MFON:ThomasAkinMember 2022-01-01 2022-12-31 0001447380 MFON:ConversionOfInterestPayableOnRelatedPartyDebtIntoCommonStockMember MFON:TalkotFundLpMember 2023-03-27 2023-03-27 0001447380 MFON:ConversionOfInterestPayableOnRelatedPartyDebtIntoCommonStockMember MFON:TalkotFundLpMember 2023-03-27 0001447380 MFON:ConversionOfInterestPayableOnRelatedPartyDebtIntoCommonStockMember MFON:TalkotFundLpMember 2022-01-01 2022-12-31 0001447380 MFON:ConversionOfInterestPayableToCommonStockMember 2023-03-01 2023-03-31 0001447380 MFON:ConversionOfInterestPayableToCommonStock2Member 2023-03-01 2023-03-31 0001447380 MFON:CommonStockPurchaseWarrantsMember 2023-03-01 2023-03-31 0001447380 MFON:CommonStockPurchaseWarrantsMember 2023-03-31 0001447380 MFON:InducementWarrantMember 2023-03-31 0001447380 us-gaap:WarrantMember MFON:InducementWarrantMember 2023-03-01 2023-03-31 0001447380 MFON:InducementWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-03-31 0001447380 MFON:InducementWarrantMember MFON:OptionFairValueMember 2023-03-31 0001447380 MFON:CommonStockOneMember 2023-06-30 0001447380 MFON:CommonStockOneMember 2023-06-30 2023-06-30 0001447380 MFON:CommonStockTwoMember 2023-06-30 0001447380 MFON:CommonStockTwoMember 2023-06-30 2023-06-30 0001447380 MFON:CommonStockPurchaseWarrantsMember 2023-08-01 2023-08-31 0001447380 MFON:CommonStockPurchaseWarrantsMember 2023-09-01 2023-09-30 0001447380 MFON:CommonStockPurchaseWarrantsMember 2023-08-31 0001447380 MFON:CommonStockPurchaseWarrantsMember 2023-09-30 0001447380 MFON:InducementWarrantMember 2023-08-31 0001447380 MFON:InducementWarrantMember 2023-09-30 0001447380 MFON:InducementWarrantMember 2023-08-01 2023-08-31 0001447380 MFON:InducementWarrantMember 2023-09-01 2023-09-30 0001447380 MFON:InducementWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-08-31 0001447380 MFON:InducementWarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-09-30 0001447380 MFON:InducementWarrantMember MFON:OptionFairValueMember srt:MinimumMember 2023-08-31 0001447380 MFON:InducementWarrantMember MFON:OptionFairValueMember srt:MinimumMember 2023-09-30 0001447380 MFON:InducementWarrantMember MFON:OptionFairValueMember srt:MaximumMember 2023-08-31 0001447380 MFON:InducementWarrantMember MFON:OptionFairValueMember srt:MaximumMember 2023-09-30 0001447380 MFON:CommonStockOneMember 2024-06-30 0001447380 MFON:CommonStockOneMember 2024-06-01 2024-06-30 0001447380 MFON:CommonStockTwoMember 2024-06-30 0001447380 MFON:CommonStockTwoMember 2024-06-01 2024-06-30 0001447380 MFON:CommonStockOneMember 2024-09-30 0001447380 MFON:CommonStockOneMember 2024-09-01 2024-09-30 0001447380 MFON:CommonStockTwoMember 2024-09-30 0001447380 MFON:CommonStockTwoMember 2024-09-01 2024-09-30 0001447380 MFON:ConversionOfInterestPayableToCommonStock2Member 2024-01-01 2024-09-30 0001447380 2023-05-11 2023-05-11 0001447380 2023-07-14 2023-07-14 0001447380 2023-07-17 2023-07-17 0001447380 2023-08-25 2023-08-25 0001447380 2024-04-01 2024-04-01 0001447380 2024-08-14 2024-08-14 0001447380 us-gaap:RestrictedStockUnitsRSUMember MFON:BoardOfDirectorsMember 2023-03-01 2023-03-31 0001447380 us-gaap:RestrictedStockUnitsRSUMember MFON:BoardOfDirectorsMember 2023-06-01 2023-06-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember MFON:BoardOfDirectorsMember 2023-09-01 2023-09-30 0001447380 MFON:FourIndependentDirectorsMember 2023-01-01 2023-09-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember MFON:BoardOfDirectorsMember 2024-03-01 2024-03-31 0001447380 us-gaap:RestrictedStockUnitsRSUMember MFON:BoardOfDirectorsMember 2024-06-01 2024-06-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember MFON:BoardOfDirectorsMember 2024-09-01 2024-09-30 0001447380 MFON:FiveIndependentDirectorsMember 2024-01-01 2024-09-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember 2024-09-30 0001447380 MFON:CommonStockWarrantsMember 2023-03-01 2023-03-31 0001447380 MFON:CommonStockWarrantsMember 2023-03-31 0001447380 us-gaap:WarrantMember MFON:CommonStockWarrantsMember 2023-03-01 2023-03-31 0001447380 MFON:CommonStockWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-03-31 0001447380 MFON:CommonStockWarrantsMember MFON:OptionFairValueMember 2023-03-31 0001447380 MFON:CommonStockWarrantsMember 2023-08-01 2023-09-30 0001447380 MFON:CommonStockWarrantsMember 2023-09-30 0001447380 us-gaap:WarrantMember MFON:CommonStockWarrantsMember 2023-08-01 2023-09-30 0001447380 MFON:CommonStockWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember 2023-09-30 0001447380 MFON:CommonStockWarrantsMember MFON:OptionFairValueMember 2023-09-30 0001447380 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001447380 us-gaap:WarrantMember 2024-03-31 0001447380 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2024-03-31 0001447380 us-gaap:WarrantMember MFON:OptionFairValueMember 2024-03-31 0001447380 us-gaap:WarrantMember 2024-04-01 2024-06-30 0001447380 us-gaap:WarrantMember 2024-06-30 0001447380 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2024-06-30 0001447380 us-gaap:WarrantMember MFON:OptionFairValueMember 2024-06-30 0001447380 us-gaap:WarrantMember 2024-07-01 2024-09-30 0001447380 us-gaap:WarrantMember 2024-09-30 0001447380 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2024-09-30 0001447380 us-gaap:WarrantMember MFON:OptionFairValueMember 2024-09-30 0001447380 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-09-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-09-30 0001447380 us-gaap:EmployeeStockOptionMember 2022-12-31 0001447380 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-12-31 0001447380 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-12-31 0001447380 us-gaap:EmployeeStockOptionMember 2023-12-31 0001447380 us-gaap:EmployeeStockOptionMember 2024-09-30 0001447380 us-gaap:GeneralAndAdministrativeExpenseMember 2024-07-01 2024-09-30 0001447380 us-gaap:GeneralAndAdministrativeExpenseMember 2023-07-01 2023-09-30 0001447380 us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-09-30 0001447380 us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-09-30 0001447380 us-gaap:SellingAndMarketingExpenseMember 2024-07-01 2024-09-30 0001447380 us-gaap:SellingAndMarketingExpenseMember 2023-07-01 2023-09-30 0001447380 us-gaap:SellingAndMarketingExpenseMember 2024-01-01 2024-09-30 0001447380 us-gaap:SellingAndMarketingExpenseMember 2023-01-01 2023-09-30 0001447380 MFON:EngineeringAndResearchAndDevelopmentExpenseMember 2024-07-01 2024-09-30 0001447380 MFON:EngineeringAndResearchAndDevelopmentExpenseMember 2023-07-01 2023-09-30 0001447380 MFON:EngineeringAndResearchAndDevelopmentExpenseMember 2024-01-01 2024-09-30 0001447380 MFON:EngineeringAndResearchAndDevelopmentExpenseMember 2023-01-01 2023-09-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001447380 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-12-31 0001447380 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001447380 us-gaap:RestrictedStockUnitsRSUMember us-gaap:GeneralAndAdministrativeExpenseMember 2024-07-01 2024-09-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-07-01 2023-09-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember us-gaap:GeneralAndAdministrativeExpenseMember 2024-01-01 2024-09-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember us-gaap:GeneralAndAdministrativeExpenseMember 2023-01-01 2023-09-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember 2024-07-01 2024-09-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember 2023-07-01 2023-09-30 0001447380 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001447380 MFON:InvestorWarrantMember 2022-12-31 0001447380 MFON:InvestorWarrantMember 2022-01-01 2022-12-31 0001447380 MFON:InvestorWarrantMember 2023-01-01 2023-12-31 0001447380 MFON:InvestorWarrantMember 2023-12-31 0001447380 MFON:InvestorWarrantMember 2024-01-01 2024-09-30 0001447380 MFON:InvestorWarrantMember 2024-09-30 0001447380 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel1Member 2024-09-30 0001447380 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel2Member 2024-09-30 0001447380 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2024-09-30 0001447380 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel1Member 2023-12-31 0001447380 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel2Member 2023-12-31 0001447380 us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:FairValueInputsLevel3Member 2023-12-31 0001447380 MFON:SecuredPromissoryNoteMember 2024-09-30 0001447380 MFON:UnsecuredPromissoryNoteMember 2024-09-30 0001447380 MFON:AssetPurchaseAgreementMember MFON:SMSFactoryIncMember 2024-09-25 0001447380 MFON:ThreeConvertibleNotesPayableMember us-gaap:SubsequentEventMember MFON:ThomasBAkinMember 2024-10-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:sqft MFON:Integer iso4217:CAD

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2024

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ___________ to __________

 

Commission file number 000-53851

 

Mobivity Holdings Corp.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada   26-3439095
(State or Other Jurisdiction of
Incorporation or Organization)
  (I.R.S. Employer
Identification No.)

 

3133 West Frye Road, # 215

Chandler, Arizona 85226

(Address of Principal Executive Offices)

 

(877) 282-7660

(Registrant’s Telephone Number, including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading symbol(s)   Name of each exchange on which registered
None   None   None

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No 

 

As of November 25, 2024, the registrant had 70,466,103 shares of common stock, par value $0.001 per share, issued and outstanding.

 

 

 

 
 

 

MOBIVITY HOLDINGS CORP.

 

TABLE OF CONTENTS

 

PART I – FINANCIAL INFORMATION   1
Item 1. Financial Statements   1
Condensed Consolidated Balance Sheets   1
Condensed Consolidated Statements of Operations and Comprehensive Loss   2
Condensed Consolidated Statement of Stockholders’ Deficit   3
Condensed Consolidated Statements of Cash Flows   4
Notes to Condensed Consolidated Financial Statements   5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   19
Item 3. Quantitative and Qualitative Disclosures about Market Risk.   25
Item 4. Controls and Procedures.   25
PART II – OTHER INFORMATION   26
Item 1. Legal Proceedings   26
Item 1A. Risk Factors   26
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   26
Item 3. Defaults Upon Senior Securities   26
Item 4. Mine Safety Disclosures   26
Item 5. Other Information   26
Item 6. Exhibits   27
SIGNATURES   28

 

 
Table of Contents

 

PART I FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Mobivity Holdings Corp.

Condensed Consolidated Balance Sheets

 

    September 30,     December 31,  
    2024     2023  
    (Unaudited)     (Audited)  
ASSETS                
Current assets                
Cash   $ 532,450     $ 416,395  
Accounts receivable, net of allowance for doubtful accounts $35,909 and $16,107, respectively    

116,748

     

29,904

 
Current assets from discontinued operations     450,517       846,561  
Other current assets     267,849       135,916  
Total current assets     1,367,564       1,428,776  
Right to use lease assets     600,624       770,623  
Intangible assets and software development costs, net     57,589       65,916  
Other assets     42,349       69,036  
TOTAL ASSETS   $ 2,068,126     $ 2,334,351  
LIABILITIES AND STOCKHOLDERS’ DEFICIT                
Current liabilities                
Accounts payable   $

586,155

    $

115,053

 

Liabilities from discontinued operations

    2,261,892       3,257,088  
Accrued interest     329,742       21,474  
Accrued and deferred personnel compensation     288,064       272,247  
Deferred revenue and customer deposits     20,684       155,472  
Related party notes payable, net - current maturities     3,840,625       3,072,500  
Notes payable, net - current maturities           7,154  
Operating lease liability, current     295,486       276,072  
Other current liabilities     468,125       248,434  
Total current liabilities     8,090,773       7,425,494  
                 
Non-current liabilities                
Related party notes payable, net - long term     8,000,858       4,413,987  
Notes payable, net - long term     224,836       265,959  
Operating lease liability     436,278       660,852  
Total non-current liabilities     8,661,972       5,340,798  
Total liabilities     16,752,745       12,766,292  
                 
Stockholders’ deficit                
Common stock, $0.001 par value; 100,000,000 shares authorized; 70,466,103 and 67,949,709, shares issued and outstanding     70,464       67,950  
Equity payable     336,420       989,947  
Additional paid-in capital     122,035,163       118,624,601  
Accumulated other comprehensive loss     62,856       (153,831 )
Accumulated deficit     (137,189,522 )     (129,960,608 )
Total stockholders’ deficit     (14,684,619 )     (10,431,941 )
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT   $ 2,068,126     $ 2,334,351  

 

See accompanying notes to consolidated financial statements.

 

1
Table of Contents

 

Mobivity Holdings Corp.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

 

    2024     2023     2024     2023  
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2024     2023     2024     2023  
Revenues                        
Revenues   $ 226,208     $ 50,180     $ 900,008     $ 183,413  
Cost of revenues     120,125       35,671     $ 541,161       122,782  
Gross profit     106,083       14,509       358,847       60,631  
                                 
Operating expenses                                
Bad Debt Expense     (7,575 )           14,849        
General and administrative     229,968       1,352,383       542,990       2,250,757  
Sales and marketing     197,713       132,518       541,762       310,323  
Engineering, research, and development     323,752       79,875       840,207       196,376  
Depreciation and amortization     612       1,038       2,812       4,022  
Total operating expenses     744,470       1,565,814       1,942,620       2,761,478  
                                 
Loss from operations     (638,387 )     (1,551,305 )     (1,583,773 )     (2,700,847 )
                                 
Other income/(expense)                                
Loss of settlement of debt     (6,514 )           (7,699 )     (370 )
Interest expense     (529,841 )     (237,376 )     (1,429,977 )     (720,265 )
Settlement Losses           (399 )           (870 )
Foreign currency gain           (3 )     (7 )     (13 )
Total other income/(expense)     (536,355 )     (237,778 )     (1,437,683 )     (721,518 )
Loss before income taxes     (1,174,742 )     (1,789,083 )     (3,021,456 )     (3,422,365 )
Income tax expense                        
Net loss from continuing operations    

(1,174,742

)    

(1,789,083

)    

(3,021,456

)    

(3,422,365

)
Loss from discontinued operations    

(1,283,810

)     (1,989,189 )     (4,207,458 )     (5,106,164 )
Net Loss     (2,458,552 )     (3,778,272 )     (7,228,914 )     (8,528,529 )
Other comprehensive loss, net of income tax            

     

     

 
Foreign currency translation adjustments     1,358       91,825       216,687       123,190  
Comprehensive loss   $ (1,173,384 )   $ (1,697,258 )   $ (2,804,769 )   $ (3,299,175 )
Basic and Diluted   $ (0.03 )   $ (0.06 )   $ (0.10 )   $ (0.13 )
Weighted average number of shares:                                
Basic and Diluted     70,482,976       66,785,952       69,719,515       64,878,021  

 

See accompanying notes to consolidated financial statements (unaudited).

 

2
Table of Contents

 

Mobivity Holdings Corp.

Condensed Consolidated Statement of StockholdersDeficit

(Unaudited)

 

    Shares     Dollars     Payable     Capital     Loss     Deficit     (Deficit)  
    Common Stock     Equity     Additional Paid-in     Accumulated Other Comprehensive     Accumulated    

Total

Stockholders’ Equity

 
    Shares     Dollars     Payable     Capital     Loss     Deficit     (Deficit)  
Balance, December 31, 2022     61,311,155     $ 61,311     $ 324,799     $ 108,806,353     $ (100,963 )   $ (117,896,409 )   $ (8,804,909 )
Issuance of common stock for warrant exercise     3,587,487       3,587             3,583,900                   3,587,487  
Issuance of common stock for settlement of interest payable on related party debt     163,757       164       (7,713 )     223,773                   216,224  
RSU’s issued - termination of director’s service     545,012       545               (545 )                      
Stock based compensation                       810,157                   810,157  
Foreign currency translation adjustment                             31,502             31,502  
Net loss                                   (2,478,175 )     (2,478,175 )
Balance, March 31, 2023     65,607,411     $ 65,607     $ 317,086     $ 113,423,638     $ (69,461 )   $ (120,374,584 )   $ (6,637,714 )
Issuance of common stock for PIPE financing                                          
Fair market value of options issued with related party debt     190,156       191       (9,768 )     216,033                   206,456  
Stock based compensation                       228,577                 $ 228,577  
Foreign currency translation adjustment                             (137 )           (137 )
Net loss                                   (2,272,082 )     (2,272,082 )
Balance, June 30, 2023     65,797,567       65,798       307,318       113,868,248       (69,598 )     (122,646,666 )     (8,474,900 )
Issuance of common stock for warrant exercise     1,960,976       1,961             1,606,039                   1,608,000  
Fair market value of options issued with related party debt                       28,463                   28,463  
Issuance of common stock for settlement of interest payable on related party debt     191,166       191       (206,456 )     206,265                    
Stock based compensation                       1,429,341                 $ 1,429,341  
Foreign currency translation adjustment                             91,825             91,825  
Net loss                                   (3,778,272 )     (3,778,272 )
Balance, September 30, 2023     67,949,709     $ 67,950     $ 100,862     $ 117,138,356     $ 22,227     $ (126,424,938 )   $ (9,095,543 )

 

    Common Stock     Equity     Additional Paid-in     Accumulated Other Comprehensive     Accumulated    

Total

Stockholders’ Equity

 
    Shares     Dollars     Payable     Capital     Loss     Deficit     (Deficit)  
Balance, December 31, 2023     67,949,709     $ 67,950     $ 989,947     $ 118,624,601     $ (153,831 )   $ (129,960,608 )   $ (10,431,941 )
Fair value of options issued with related party debt                         466,594                   466,594  
Stock based compensation - Employees                       112,660                   112,660  
Stock Based Compensation - Directors                             81,250                   81,250  
Foreign currency translation adjustment                             217,929             217,929  
Net loss                                 $ (2,254,242 )     (2,254,242 )
Balance, March 31, 2024     67,949,709     $ 67,950     $ 989,947     $ 119,285,105     $ 64,098     $ (132,214,850 )   $ (11,807,750 )
Fair value of options issued with related party debt                         619,191                   619,191  
Issuance of common stock for settlement of interest payable on related party debt                 465,996                           465,996  
Stock based compensation - Employees                       131,414                   131,414  
Stock based compensation -Directors                             81,249                       81,249  
Foreign currency translation adjustment                             (2,600 )           (2,600 )
Net loss                                 $ (2,516,120 )     (2,516,120 )
Balance, June 30, 2024     67,949,709     $ 67,950     $ 1,455,943     $ 120,116,959     $ 61,498     $ (134,730,970 )   $ (13,028,620 )
Issuance of common stock for settlement of interest payable on related party debt     2,516,394       2,514       (1,355,081 )     1,389,977                   37,410  
Interest Payable on related party debt recorded to equity payable                     235,558                               235,558  
Fair market value of options issued with related party debt                       298,188                   298,188  
Stock based compensation - Employees                       148,789                   148,789  
Stock Based Compensation - Directors                             81,250                       81,250  
Foreign currency translation adjustment                             1,358             1,358  
Net loss                                 $ (2,458,552 )     (2,458,552 )
Balance, September 30, 2024     70,466,103       70,464       336,420       122,035,163       62,856       (137,189,522 )     (14,684,619 )

 

See accompanying notes to consolidated financial statements (unaudited).

 

3
Table of Contents

 

Mobivity Holdings Corp.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

    2024     2023  
    Nine Months Ended  
    September 30,  
    2024     2023  
OPERATING ACTIVITIES                
Net Loss   $ (7,228,914 )   $ (8,528,529 )
Net loss from discontinued operations    

4,207,458

     

5,106,164

 
Adjustments to reconcile net loss to net cash used in operating activities:                
Loss on Settlement of Debt - related party    

37,410

      10,857  
Bad debt expense     14,849        
Stock-based compensation    

636,612

         
Loss on disposal of fixed assets            
Intangible Asset Impairment            
Depreciation and amortization expense     48,341       162,209  
Amortization of Debt Discount     372,847       89,349  
Increase (decrease) in cash resulting from changes in:                
Accounts receivable     (101,693 )     683,060  
Other current assets           9,634  
Other assets           (13,250 )
Accounts payable     471,102     104,093  
Prepaid Expenses     (131,933 )     (46,231 )
Accrued interest     1,009,822       621,806  
Accrued and deferred personnel compensation     15,939       (457,687 )
Other liabilities - current     219,691       (34,036 )
Lease Operating Assets     (35,161 )     (30,155 )
Deferred revenue and customer deposits    

(134,788

)     (684,175 )
Net Cash Used in Operating Activities of continuing operations    

(598,418

)    

(3,006,891

)
Net Cash Used in Operating Activities of discontinuing operations    

(4,806,610

)    

(2,638,089

)
Net cash used in operating activities   $ (5,405,028 )   $ (5,644,980 )
                 
INVESTING ACTIVITIES                
Cash paid for patent activities     (8,768 )     (6,300 )
Purchases of equipment     (4,559 )     (18,252 )
Net cash used in investing activities     (13,327 )     (24,552 )
                 
FINANCING ACTIVITIES                
Payments on notes payable     (7,035 )     (20,004 )
Proceeds from Related Party Debt     5,325,000       400,000  
Proceeds from conversion of common stock warrants    

      5,195,487  
Net cash provided by (used in) financing activities     5,317,965       5,575,483  
                 
Effect of foreign currency translation on cash flow     216,445       125,243  
                 
Net Change in cash     116,055       31,194  
Cash at beginning of period   $ 416,395     $ 426,740  
Cash at end of period     532,450       457,934  
Supplemental disclosures                
Interest paid   $

11,571

    $

9,110

 
                 

Non-cash investing and financing activities:

               
Fair Value of Options issued with related party debt   $ 1,389,673     $ 28,463  
Shares Issued for settlement of debt           411,823  
Shares issued for settlement of debt - related party   701,554     223,937  
Par Value of RSU’s issued - termination of director’s service   $     $ 545  

 

See accompanying notes to consolidated financial statements.

 

4
Table of Contents

 

Mobivity Holdings Corp.

Notes to Condensed Consolidated Financial Statements

(Unaudited)

 

1. Nature of Operations and Basis of Presentation

 

Mobivity Holdings Corp. (the “Company” or “us”, “our”, or “we”) is a Nevada corporation organized in 2008, which develops and operates proprietary platforms over which brick and mortar brands and digital first enterprises can conduct national and localized, data-driven marketing campaigns with unique targeting, incentivization and promotion to drive customer acquisition and loyalty. The company’s core technology platform, RecurrencyTM, enables:

 

  Transformation of messy point-of-sale (POS) data collected from thousands of points of sale into usable intelligence.
  Measurement, prediction, and ability to boost guest frequency and spend by channel.
  Deployment and management of one-time use offer codes and attribution of sales accurately across every channel, promotion and media program.
  Delivery of uniquely attributable 1:1 offers that power incentivized actions in digital environments like user acquisition, continued monetization, and activities taken in a digital environment.

 

Our recurrency platform generates revenue in two ways. First, delivered as a Software-as-a-Service (“SaaS”) platform used by leading convenience and quick service restaurant brands to build and engage with their loyal customers. Second, through our Connected RewardsTM business, our platform enables and powers unique incentivized programs in digital environments. Through our Connected Rewards platform, we enable businesses to reward their users and customers with products in the real world for actions taken in a digital environment. Our customers include some of the largest mobile casual game publishers in the world and some of the largest convenience and quick service restaurant brands in the world. The programs we run for our customers include incentivized user acquisition where users are rewarded with a real-world product, like a free or discounted burger, for downloading a mobile game, and rewarded play where users receive real world products for accomplishing activities in game, like achieving a certain level or winning enough points. We charge our customers for each unique action where our rewards are delivered, these include a per install or per individual engagement fee.

 

On September 25, 2024, the Company entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with SMS Factory, Inc., a Florida corporation (“SMS Factory”). Pursuant to the Asset Purchase Agreement, SMS Factory purchased all of the right, title and interest in the Company’s SMS/MMS text messaging customer accounts, excluding certain Excluded Assets (as defined in the Asset Purchase Agreement) utilized in the operation of the Company’s SMS/MMS text messaging platform business (the “Business Assets”) effective as of September 25, 2024 (the “Closing Date”). Given that the effect of the Asset Purchase Agreement meets all the initial criteria of ASC Topic 205-20, Presentation of Financial Statements Discontinued Operations for the classification of discontinued operations, the assets, liabilities, and operating results of Mobivity Holdings Corp have been classified as discontinued operations as of September 30, 2024 and December 31, 2023 and for the three and nine months ended September 30, 2024 and 2023. The consolidated financial statements for the prior periods have been adjusted to reflect comparable information.

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 8-03 of Regulation S-X promulgated by the Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and disclosures required by GAAP for annual financial statements. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on April 16, 2024.

 

In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of our condensed consolidated financial statements as of September 30, 2024, and for the three and nine months ended September 30, 2024 and 2023. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of the operating results for the full year ending December 31, 2024.

 

2. Summary of Significant Accounting Policies

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Management believes that these estimates are reasonable; however, actual results may differ from these estimates.

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform to the current year’s presentation. The reclassifications did not affect previously reported net losses.

 

Acquisitions

 

We account for acquired businesses using the purchase method of accounting. Under the purchase method, our consolidated financial statements reflect the operations of an acquired business starting from the completion of the acquisition. In addition, the assets acquired and liabilities assumed are recorded at the date of acquisition at their respective estimated fair values, with any excess of the purchase price over the estimated fair values of the net assets acquired recorded as goodwill.

 

Cash

 

We minimize our credit risk associated with cash by periodically evaluating the credit quality of our primary financial institution. Our balances at times may exceed federally insured limits. We have not experienced any losses on our cash accounts.

 

Accounts Receivable, Allowance for Doubtful Accounts and Concentrations

 

Accounts receivable are carried at their estimated collectible amounts. We grant unsecured credit to substantially all of our customers. Ongoing credit evaluations are performed, and potential credit losses are charged to operations at the time the account receivable is estimated to be uncollectible. Since we cannot necessarily predict future changes in the financial stability of our customers, we cannot guarantee that our reserves will continue to be adequate.

 

As of September 30, 2024, and December 31, 2023 we recorded an allowance for doubtful accounts of $35,909 and $16,107, respectively.

 

Goodwill and Intangible Assets

 

Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit.

 

5

 

We conducted our annual impairment tests of goodwill as of December 31, 2023. As a result of these tests, we had a total impairment charge of $0.

 

Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, non-compete agreements, and software development costs. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one year to twenty years. No significant residual value is estimated for intangible assets.

 

The Company’s evaluation of its goodwill and intangible assets resulted in no impairment charges for the nine months ended September 30, 2024 and 2023, respectively.

 

Software Development Costs

 

Software development costs include direct costs incurred for internally developed products and payments made to independent software developers and/or contract engineers. The Company accounts for software development costs in accordance with the Financial Accounting Standards Board (“FASB”) guidance for the costs of computer software to be sold, leased, or otherwise marketed (Accounting Standards Codification subtopic 985-20, Costs of Software to Be Sold, Leased, or Marketed, or “ASC Subtopic 985-20”). Software development costs are capitalized once the technological feasibility of a product is established, and such costs are determined to be recoverable. The technological feasibility of a product encompasses technical design documentation and integration documentation, or the completed and tested product design and working model. Software development costs are capitalized once the technological feasibility of a product is established and such costs are determined to be recoverable against future revenues. Technological feasibility is evaluated on a project-by-project basis. Amounts related to software development that are not capitalized are charged immediately to the appropriate expense account. Amounts that are considered “research and development” that are not capitalized are immediately charged to engineering, research, and development expense.

 

Capitalized costs for those products that are canceled or abandoned are charged to product development expenses in the period of cancellation. Commencing upon product release, capitalized software development costs are amortized to “Amortization Expense - Development” based on the straight-line method over a twenty-four-month period.

 

The Company evaluates the future recoverability of capitalized software development costs on an annual basis. For products that have been released in prior years, the primary evaluation criterion is ongoing relations with the customer. The Company’s evaluation of its capitalized software development assets resulted in no impairment charges for the three months ended September 30, 2024 and 2023, respectively.

 

Impairment of Long-Lived Assets

 

We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.

 

Foreign Currency Translation

 

The Company translates the financial statements of its foreign subsidiary from the local (functional) currency into US Dollars using the year or reporting period end or average exchange rates in accordance with the requirements of ASC subtopic 830-10, Foreign Currency Matters (“ASC 830-10”). Assets and liabilities of these subsidiaries were translated at exchange rates as of the balance sheet date. Revenues and expenses are translated at average rates in effect for the periods presented. The cumulative translation adjustment is included in the accumulated other comprehensive gain (loss) within shareholders’ equity. Foreign currency transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the unaudited Condensed Consolidated Statements of Income and Comprehensive Income.

 

Revenue Recognition and Concentrations

 

Our Recurrency platform is a hosted solution. We generate revenue from licensing our software to clients in our software as a service model, per-message and per-minute transactional fees, and customized professional services. We recognize license/subscription fees over the period of the contract, service fees as the services are performed, and per-message or per-minute transaction revenue when the transaction takes place. Under ASC 606, revenue is recognized when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration we expect to be entitled to in exchange for those goods or services. We consider authoritative guidance on multiple deliverables in determining whether each deliverable represents a separate unit of accounting. Some customers are billed on a month-to-month basis with no contractual term and fees are collected by credit card. Revenue is recognized at the time that the services are rendered, and the selling price is fixed with a set range of plans. Cash received in advance of the performance of services is recorded as deferred revenue.

 

Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (“ASC 606”), is a comprehensive revenue recognition standard that superseded nearly all existing revenue recognition guidance. The Company adopted this standard effective January 1, 2018, applying the modified retrospective method. Upon adoption, the Company discontinued revenue deferral under the sell-through model and commenced recording revenue upon delivery to distributors, net of estimated returns. Generally, the new standard results in earlier recognition of revenues.

 

We determine revenue recognition under ASC 606 through the following steps:

 

  identification of the contract, or contracts, with a customer;
  identification of the performance obligations in the contract;
  identification of the transaction price;
  allocation of the transaction price to the performance obligations in the contract; and
  recognition of revenue when, or as, we satisfy a performance obligation.

 

During the nine months ended September 30, 2024 and 2023, two customers accounted for 52% and 51% of our revenues, respectively.

 

6

 

Comprehensive Loss

 

Comprehensive loss is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We are required to record all components of comprehensive loss in the consolidated financial statements in the period in which they are recognized. Net loss and other comprehensive loss, including foreign currency translation adjustments and unrealized gains and losses on investments, are reported, net of their related tax effect, to arrive at a comprehensive loss. For the three months ended September 30, 2024 and 2023, the comprehensive loss was $1,173,384, and $1,697,258 respectively. For the nine months ended September 30, 2024 and 2023, the comprehensive loss was $2,804,769 and $3,299,175 respectively.

 

Stock-based Compensation

 

We primarily issue stock-based awards to employees in the form of stock options. We determine compensation expense associated with stock options based on the estimated grant date fair value method using the Black-Scholes valuation model. We recognize compensation expense using a straight-line amortization method over the respective vesting period.

 

Research and Development Expenditures

 

Research and development expenditures are expensed as incurred, and consist primarily of compensation costs, outside services, and expensed materials.

 

Advertising Expense

 

Direct advertising costs are expensed as incurred and consist primarily of trade shows, sales enablement, content creation, paid engagement and other direct costs. Advertising expense was $151,953 and $169,549 for the nine months ended September 30, 2024 and 2023, respectively.

 

Income Taxes

 

We account for income taxes using the assets and liability method, which recognizes deferred tax assets and liabilities determined based on the difference between the financial statement and tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets when, based on available objective evidence, it is more likely than not that the benefit of such assets will not be realized. We recognize in the consolidated financial statements only those tax positions determined to be more likely than not of being sustained.

 

Net Loss Per Common Share

 

Basic net loss per share excludes any dilutive effects of options, shares subject to repurchase, and warrants. Diluted net loss per share includes the impact of potentially dilutive securities. During the three and nine months ended September 30, 2024 and 2023, we had securities outstanding which could potentially dilute basic earnings per share in the future. Stock-based compensation, stock options and warrants were excluded from the computation of diluted net loss per share when their effect would have been anti-dilutive.

 

Recent Accounting Pronouncements

 

Accounting standards promulgated by the FASB are subject to change. Changes in such standards may have an impact on the Company’s future financial statements. The following is a summary of recent accounting developments.

 

In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”). ASU 2020-06 requires that the if-converted method of computing diluted Earnings per Share. The Company adopted ASU 2020-06 on January 1, 2022.

 

3. Discontinued Operations

 

On September 25, 2024, the Company entered into an Asset Purchase Agreement (the “Asset Purchase Agreement”) with SMS Factory, Inc., a Florida corporation (“SMS Factory”). Pursuant to the Asset Purchase Agreement, SMS Factory purchased all of the right, title and interest in the Company’s SMS/MMS text messaging customer accounts, excluding certain Excluded Assets (as defined in the Asset Purchase Agreement) utilized in the operation of the Company’s SMS/MMS text messaging platform business (the “Business Assets”) effective as of September 25, 2024 (the “Closing Date”).

 

The following table presents a reconciliation of the carrying amounts of the major classes of these assets and liabilities to the current assets and liabilities of discontinued operations as presented on the Company’s Consolidated Balance Sheets:

 

    As of September 30, 2024     As of December 31,2023  
Assets           $  
Current assets                
Accounts receivable   $ 450,517     $ 846,561  
                 
Total Assets   $ 450,517     $ 846,561  
                 
Liabilities                
Current liabilities                
Accounts Payable   $ 2,261,892     $ 3,257,088  
                 
Total Liabilities   $ 2,261,892     $ 3,257,088  

 

The following table provides details about the major classes of line items constituting “Income (loss) from discontinued operations” as presented on the Company’s Consolidated Statements of Loss:

 

    2024     2023     2024     2023  
    Three Months Ended
September 30,
    Nine Months Ended
September 30,
 
    2024     2023     2024     2023  
Revenues   $ 1,072,865     $ 1,582,891     $ 3,473,012     $ 5,192,311  
Cost of Revenue     570,704       1,125,209       2,093,161       3,475,879  
Gross Profit     502,161       457,682       1,379,851       1,716,432  
                                 
Operating Expenses                                
Bad Debt Expense     (29,232 )           70,428        
General and administrative     476,788       940,240       1,381,340       2,657,125  
Sales and marketing     566,510       575,880       1,837,504       1,692,206  
Engineering, research and development     738,649       888,671       2,254,966       2,310,888  
Depreciation and amortization     2,360       29,380       13,335       126,880  
Total operating expenses     1,755,075       2,434,171       5,557,573       6,787,099  
                                 
Loss from Operations     (1,252,914 )     (1,976,489 )     (4,177,722 )     (5,070,667 )
                                 
Other income/(expense)                                
Loss on settlement of debt     (30,896 )           (29,711 )     (10,487 )
Interest expense                        
Settlement Losses           (12,601 )           (24,630 )
Foreign currency gain           (99 )     (25 )     (380 )
Total other income/(expense)     (30,896 )     (12,700 )     (29,736 )     (35,497 )
                                 
Net Loss from Discontinued Operations   $ (1,283,810 )   $ (1,989,189 )   $ (4,207,458 )   $ (5,106,164 )

 

The Company’s execution of the Asset Purchase Agreement has met the criteria to be reported as discontinued operations. In accordance with GAAP, assets and liabilities of discontinued operations are presented separately in the Consolidated Balance Sheets, and results of discontinued operations are reported as a separate component of Consolidated net loss in the Consolidated Statements of Loss, for all periods presented, resulting in changes to the presentation of certain prior period amounts. Cash flows from discontinued operations are not reported separately in the Consolidated Statements of Cash Flows. The assets and liabilities of discontinued operations are presented separately in the Consolidated Balance Sheets for all periods presented.

 

4. Going Concern

 

We had $532,450 of cash as of September 30, 2024. We had a net loss of $7,228,914 for the nine months ended September 30, 2024, and we used $5,405,028 of cash in our operating activities during that time. In the nine months ended September 30, 2023 we had a net loss of $8,528,529  and used $5,644,980 of cash in our operating expenses. We raised $3.0 million in cash Convertible Notes issued during 2023. We raised an additional $5.3 million from the issuance of convertible notes in 2024. There is substantial doubt that our additional cash from our warrant conversion along with our expected cash flow from operations, will be sufficient to fund our 12-month plan of operations, and there can be no assurance that we will not require significant additional capital within 12 months.

 

As shown in the accompanying financial statements, the Company has incurred net losses from operations resulting in an accumulated deficit of $137.2 million as of September 30, 2024. Further losses are anticipated in the development of the Company’s business raising substantial doubt about the Company’s ability to continue as a going concern. The ability to continue as a going concern is dependent upon the Company generating profitable operations in the future and/or obtaining the necessary financing to meet its obligations and repay its liabilities arising from normal business operations when they come due. Management intends to finance operating costs over the next 12 months with proceeds from the sale of securities, and/or revenues from operations. These financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts, or amounts and classification of liabilities that might result from this uncertainty.

 

7

 

4. Intangibles

 

Intangible assets

 

The following table presents details of our purchased intangible assets as of September 30, 2024 and December 31, 2023:

 

    Balance at December 31, 2023     Additions     Impairments     Amortization     Foreign Exchange and Other     Balance at September 30, 2024  
Patents and trademarks   $             53,663     $ 8,768     $     $ (4,930 )   $     $              57,501  
Customer and merchant relationships     6,138                 $ (6,138 )            
Trade names     1,609                 $ (1,609 )            
    $ 61,410     $ 8,768     $     $ (12,677 )   $     $ 57,501  

 

The intangible assets are being amortized on a straight-line basis over their estimated useful lives of one year to twenty years.

 

Amortization expense for intangible assets was $12,677 and $28,689 for the nine months ended September 30, 2024 and 2023, respectively, and is included in depreciation and amortization on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss.

 

Amortization expense for intangible assets was $1,819 and $10,747 for the three months ended September 30, 2024 and 2023, respectively.

 

The estimated future amortization expense of our intangible assets as of September 30, 2024 was as follows:

 

Year ending December 31,   Amount  
2024   $ 1,811  
2025   $ 7,246  
2026   $ 7,246  
2027   $ 7,246  
2028   $ 7,246  
Thereafter   $ 26,706  
Total   $ 57,501  

 

5. Software Development Costs

 

The Company has capitalized certain costs for software developed or obtained for internal use during the application development stage as it relates to specific contracts. The amounts capitalized include external direct costs of services used in developing internal-use software and for payroll and payroll-related costs of employees directly associated with the development activities.

 

The following table presents details of our software development costs as of September 30, 2024 and December 31, 2023:

 

   

Balance at

December 31,

2023

    Additions     Amortization    

Balance at

September 30,

2024

 
Software Development Costs   $ 4,506     $     $ (4,418 )   $ 88  
    $ 4,506     $     $ (4,418 )   $ 88  

 

Software development costs are being amortized on a straight-line basis over their estimated useful life of two years.

 

8

 

Amortization expense for software development costs was $1,140 and $18,120 for the three months ended September 30, 2024 and 2023, respectively, and is included in depreciation and amortization on the accompanying unaudited condensed consolidated statements of operations and comprehensive loss.

 

Amortization expense for software development costs was $4,418 and $95,694 for the nine months ended September 30, 2024 and 2023, respectively.

 

The estimated future amortization expense of software development costs as of September 30, 2024 is as follows:

 

Year ending December 31,   Amount  
2024   $ 88  
2025      
2026      
2027      
2028      
Thereafter      
Total   $ 88  

 

6. Operating Lease Assets

 

The Company entered into a lease agreement on February 1, 2021, for 8,898 square feet, for its office facilities in Chandler, AZ through January 2027. Monthly rental payments, excluding common area maintenance charges, are $25,953 to $28,733. The first twelve months of the lease included a 50% abatement period and a deposit of $110,000 was required. The lessor contributed $110,000 towards the purchase of office furniture as part of the lease agreement. As of September 30, 2024, we have an operating lease asset balance of $600,624 and an operating lease liability balance of $731,764 recorded in accordance with ASC 842, Leases (ASC “842”).

 

The Company entered in to a sublease on March 1, 2024 for its office facilities in Chandler, AZ through February 28, 2025. Monthly rental payments including rental of office furniture and excluding taxes, are $24,470.

 

The following are additional details related to leases recorded on our balance sheet as of September 30, 2024:

 

Leases   Classification  

Balance at

September 30,

2024

 
Assets            
Current            
Operating lease assets   Operating lease assets   $  
Noncurrent            
Operating lease assets   Noncurrent operating lease assets   $ 600,624  
Total lease assets       $ 600,624  
             
Liabilities            
Current            
Operating lease liabilities   Operating lease liabilities   $ 295,486  
Noncurrent            
Operating lease liabilities   Noncurrent operating lease liabilities   $ 436,278  
Total lease liabilities       $ 731,764  

 

9

 

The maturity analysis below summarizes the remaining future undiscounted cash flows for our operating leases, a reconciliation to operating lease liabilities reported on the Condensed Consolidated Balance Sheet, our weighted-average remaining lease term, and weighted average discount rate:

 

Year ending December 31,      
2024   $ 82,863  
2025     337,568  
2026     344,241  
2027     28,733  
2028      
Thereafter      
Total future lease payments     793,405  
Less: imputed interest     (61,641 )
Total   $ 731,764  

 

Weighted Average Remaining Lease Term (years)        
Operating leases     2.33  
         
Weighted Average Discount Rate        
Operating leases     6.75 %

 

7. Notes Payable and Interest Expense

 

The following table presents details of our notes payable as of September 30, 2024 and December 31, 2023:

 

Facility   Maturity   Interest Rate    

Balance at

September 30,

2024

   

Balance at

December 31,

2023

 
ACOA Note   February 1, 2024     15 %           7,154  
Related Party Secured Promissory Note   June 30, 2026     8 %     5,718,738       5,677,251  
Related Party Convertible Notes   various     15 %     5,850,870       1,587,361  
Related Party Unsecured Promissory Note   June 30,2026     8 %     271,875       271,875  
Convertible Notes   Various     15 %     224,836       215,959  
Total Debt                 12,066,319       7,759,600  
Less current portion                 (3,840,625 )     (3,079,654 )
Long-term debt, net of current portion               $ 8,225,694     $ 4,679,946  

 

ACOA Note

 

On November 6, 2017, Livelenz (a wholly owned subsidiary of the Company), entered into an amendment of the original agreement dated December 2, 2014, with the Atlantic Canada Opportunities Agency (“ACOA”). Under this agreement, the note will mature, and the commitments will terminate, on February 1, 2024. The monthly principal payment amount of $3,000 CAD increased to $3,500 CAD beginning on November 1, 2019, $4,000 CAD on August 1, 2021, $4,500 CAD on August 1, 2022, and $2,215 CAD during the remaining term of the agreement. Payments from April-December of 2020 were voluntarily deferred by ACOA due to COVID-19.

 

During the nine months ended September 30, 2024 we repaid $7,035 USD of principal. The final payment was made on February 28, 2024 and the loan is paid in full.

 

10

 

Related Party Notes

 

Secured Promissory Notes

 

On June 30, 2021, we entered into a Credit Facility Agreement (the “Credit Agreement”) with Thomas Akin, one of the Company’s directors (the “Lender”). The Credit Agreement was amended on November 11, 2022. The Company can borrow up to $6,000,000 under the Credit Agreement (“the “Credit Facility”).

 

The Credit Facility is secured by all of our tangible and intangible assets including intellectual property. This loan bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum. The Company may prepay this loan without notice, penalty, or charge. In consideration of the Lender’s agreement to provide the Credit Facility, the Company issued warrants to purchase shares of its common stock at an exercise price of $1.67 per share in connection with the issuance of funds under the Credit Agreement. The warrants are exercisable for a period commencing upon issuance of the corresponding notes and ending 36 months after issuance of the financing. In addition, the Company has agreed to issue to the Lender additional warrants entitling the Lender to purchase a number of shares of the Company’s common stock equal to twenty percent (20%) of the amount of the advances made divided by the volume-weighted average price over the 30 trading days preceding the advance (the “VWAP”). Each warrant will be exercisable over a three-year period at an exercise price equal to the VWAP.

 

Under the original terms of the Credit Agreement, the Company was to begin repaying the principal amount, plus accrued interest, in 24 equal monthly installments commencing on June 30, 2022, and ending on June 30, 2024. On November 11, 2022, an amendment to the Credit Agreement was signed. The amendment updated the payment terms to the following: “Without limiting the foregoing Section 2.3(a), Borrower shall repay the principal amount of all Advances, plus accrued interest thereon, in 24 equal monthly installments commencing on January 31, 2023 and continuing thereafter on the last day of each month (or, if such last day is not a Business Day, on the Business Day immediately preceding such last day. Interest on the unpaid Advances will accrue from the date of each Advance at a rate equal to fifteen percent (15%) per annum. Interest will be calculated on the basis of 365 days in a year.” The amendment raised the maximum amount of the Credit Facility to $6,000,000. In addition, the interest which is accrued monthly between July 1, 2022, and December 31, 2022, will be settled into equity. Common Stock will be issued at the end of each month at a rate of $1.08 per share of common stock in the amount of the interest accrued for each month.

 

On January 31, 2023, the Company then entered into Amendment No. 1 (the “Amendment”), which amends our existing Credit Facility Agreement[1], dated as of November 11, 2022, between the Company and Thomas B. Akin, and any convertible notes issued thereunder. The Amendment amends the existing Credit Facility Agreement to extend the maturity of the agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a period beginning on January 1, 2024 and ending December 1, 2025, and further provides that any accrued interest on unpaid advances under the agreement is to be paid quarterly in shares of our common stock, at a price per share equal to the volume-weighted average price of our common stock quoted on the Over-The Counter Venture Market operated by OTC Markets Group Inc. (“OTCQB®”) over the ninety (90) trading days immediately preceding such date. The Amendment provides for corresponding amendments to the form of convertible notes to be issued under the Credit Agreement in the future and any outstanding convertible notes issued under the existing Credit Facility Agreement. The Amendment was considered a debt modification as the cash flows under the amended terms do not differ by at least 10% from the cash flows under the original agreement.

 

On January 31, 2024 amended terms were agreed upon and the Company then entered into Amendment No. 2 (the “Amendment”) signed on May 3,2024, which amends the terms of the Credit Facility Agreement, between the Company and Thomas B. Akin, and any convertible notes issued thereunder. The Amendment amends the existing Credit Facility Agreement to extend the maturity of the agreement and related convertible notes thereunder until June 30, 2026. Principal payments have been deferred to a period beginning on July 31, 2024 and ending June 30, 2026.

 

On August 13, 2024 amended terms were agreed upon and the Company then entered into Amendment No. 3 (the “Amendment”) signed on May 3,2024, which amends the terms of the Credit Facility Agreement, between the Company and Thomas B. Akin, and any convertible notes issued thereunder. The Amendment amends the existing Credit Facility Agreement to extend the maturity of the agreement and related convertible notes thereunder until June 30, 2026. Principal payments have been deferred to a period beginning on October 31, 2024 and ending September 30, 2026.

 

During the nine months ended September 30, 2024, a total of $681,432 of interest was accrued by the company. The company recorded amortized discount expense of $64,053.

 

As of September 30, 2024, the Company had drawn a total of $5,873,125, with a debt discount of $201,087 for a net principal balance of $5,672,038 and has equity payable balance $336,417.

 

Related Party Convertible Notes

 

During fourth quarter 2023 the Company issued 8 Convertible Notes payable to related parties for $2,000,000. As an inducement we issued 3,333,332 warrants to purchase shares of our common stock at $.60 per share. Simple interest on the unpaid principal balance of this Note will accrue at the rate of 8.0% per annum. Accrual of interest will commence on the date of this Note, will continue until this Note is fully paid, and will be payable in a single installment at maturity three years from the date the Convertible Note was issued.

 

The Convertible Note and all accrued interest thereon are convertible into shares of our common stock, from time to time, at the option of the holder thereof, at a conversion price per share equal to the larger of either $0.50 or of the volume-weighted average price of our common stock quoted on the OTCQB ® Venture Market operated by OTC Markets Group Inc. over the thirty (30) trading days immediately preceding such date (the “Conversion Price”).

 

11

 

During first quarter 2024 the Company issued 8 Convertible Notes payable to related parties for $1,950,000. As an inducement we issued 3,249,997 warrants to purchase shares of our common stock at $.60 per share. Simple interest on the unpaid principal balance of this Note will accrue at the rate of 8.0% per annum. Accrual of interest will commence on the date of this Note, will continue until this Note is fully paid, and will be payable in a single installment at maturity three years from the date the Convertible Note was issued.

 

During the second quarter of 2024 the Company issued 8 Convertible Notes payable to related parties for $2,100,000. As an inducement we issued 3,499,997 warrants to purchase shares of our common stock at $.60 per share. Simple interest on the unpaid principal balance of this Note will accrue at the rate of 8.0% per annum. Accrual of interest will commence on the date of this Note, will continue until this Note is fully paid, and will be payable in a single installment at maturity three years from the date the Convertible Note was issued.

 

During the third quarter of 2024 the Company issued 4 Convertible Notes payable to related parties for $1,275,000. As an inducement we issued 2,124,999 warrants to purchase shares of our common stock at $.60 per share. Simple interest on the unpaid principal balance of this Note will accrue at the rate of 8.0% per annum. Accrual of interest will commence on the date of this Note, will continue until this Note is fully paid, and will be payable in a single installment at maturity three years from the date the Convertible Note was issued.

 

During the nine months ended September 30, 2024 accrued interest of $293,735 was recorded in connection with the related party convertible notes. The Company recorded $299,917 in amortized debt discount in connections with related party convertible notes.

 

As of September 30, 2024 the Convertible Notes issued to related parties had a principal balance of $7,325,000 with a debt discount of $1,425,974 for a net principal balance of $5,899,026 and accrued interest of $313,233.

 

Unsecured Promissory Note

 

On July 1, 2021, we entered into UP Notes in the aggregate principal amount of $271,875 with Talkot Fund, LP and investor in the Company. Each UP Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest are due and payable no later than December 31, 2023. We may prepay any of the UP Notes without notice, subject to a two percent (2%) pre-payment penalty. The UP Note offer was conducted by our management and there were no commissions paid by us in connection with the solicitation. The Company issued to Talkot Fund LP warrants to purchase an aggregate of 33,017 shares of its common stock at the stated exercise price per share in connection with the issuance of funds under this UP Note.

 

On January 31, 2023, the Lender agreed to postpone the 24-month repayment period to a later period commencing on January 31, 2024, and further agreed that interest accrued on the loan between July 1, 2022 and December 1, 2025 is to be settled in shares of the Company’s common stock quarterly.

 

On January 31 2024, the Lender agreed to postpone the 24-month repayment period to a later period commencing on July 31, 2024.

 

During the nine months ended September 30, 2024, a total of $20,122 of interest was accrued by the company and recorded to equity payable.

 

As of September 30, 2024, the Company had an outstanding principal balance of $271,875, an equity payable balance of $20,122 of accrued interest.

 

Convertible Notes

 

During fourth quarter 2023 the Company issued 10 Convertible Notes payable to related parties for $250,000. As an inducement we issued 416,667 warrants to purchase shares of our common stock at $.60 per share. Simple interest on the unpaid principal balance of this Note will accrue at the rate of 8.0% per annum. Accrual of interest will commence on the date of this Note, will continue until this Note is fully paid, and will be payable in a single installment at maturity three years from the date the Convertible Note was issued.

 

The Convertible Note and all accrued interest thereon are convertible into shares of our common stock, from time to time, at the option of the holder thereof, at a conversion price per share equal to the larger of either $0.50 or of the volume-weighted average price of our common stock quoted on the OTCQB ® Venture Market operated by OTC Markets Group Inc. over the thirty (30) trading days immediately preceding such date (the “Conversion Price”)

 

During the nine months ended September 30, 2024 the company recorded accrued interest of $15,222 in connection with convertible notes and $8,876 in amortized debt discount.

 

As of September 30, 2024 the Convertible Notes had a principal balance of $250,000 with a debt discount of $25,165 for a net principal balance of $224,835 and accrued interest of $16,509.

 

Interest Expense

 

Interest expense was $529,841 and $237,376 during the three months ended September 30, 2024 and 2023, respectively.

 

Interest expense was $1,429,977 and $720,265 during the nine months ended September 30, 2024 and 2023, respectively.

 

12

 

8. Stockholders’ Equity

 

Common Stock and Equity Payable

 

2023

 

On January 31, 2023 a total of 545,012 shares were issued to John Harris, a former director. The shares were issued based on the total Restricted Stock Units earned by Mr. Harris as director compensation that were fully vested as of March 29, 2022. Restricted stock expense is recorded on the date it vests and no expense was recognized during the six months ended June 30, 2023.

 

On March 27, 2023 a total of 154,106 shares of common stock were granted from equity payable to Thomas Akin as settlement of $166,432 of interest payable. The Company recorded a loss on settlement of interest payable of $44,325 on December 31, 2022.

 

On March 27, 2023 a total of 9,651 shares of common stock were granted from equity payable to Talkot Fund LP as settlement of $10,423 of interest payable. The Company recorded a loss on settlement of interest payable of $2,757 on December 31, 2022.

 

On March 31, 2023 a total of $195,171 of interest was accrued and settled to equity payable for the issuance of 180,715 shares of common stock. The company recorded a loss of settlement of interest payable of $10,315.

 

On March 31, 2023 a total of $10,196 of interest was accrued and settled to equity payable for the issuance of 9,441 shares of common stock. The company recorded a loss of settlement of interest payable of $542.

 

During March of 2023, 15 warrant holders exercised their common stock purchase warrant for 3,587,487 shares at the exercise price of $1.00 per share, resulting in additional capital of $3,587,487. As an inducement for the holder’s exercise of the warrants, we issued the holders’ 1,792,745 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in March 2026. The Company recorded $577,000 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

 

On June 30, 2023 a total of $196,148 of interest was accrued and settled to equity payable for the issuance of 181,620 shares of common stock.

 

On June 30, 2023 a total of $10,309 of interest was accrued and settled to equity payable for the issuance of 9,546 shares of common stock.

 

During August and September of 2023, 18 warrant holders exercised their common stock purchase warrant for 1,960,976 shares at the exercise price of $.82 per share, resulting in additional capital of $1,608,000. As an inducement for the holder’s exercise of the warrants, we issued the holders’ 3,921,952 new warrants to purchase common stock at $.82 per share over a one and three-year period expiring between August and September 2026. The Company recorded $1,146,562 of stock-based expense related to warrants issued during the warrant conversion offer on September 6, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on an average volatility rate of 63% and 73% and an option fair value of between $0.21 and $0.40.

 

During the nine months ended September 30, 2023 a total of 163,757 shares were issued from stock payable related to related party accrued interest.

 

As of the September 30, 2023 we had an equity payable balance of $100,862.

 

2024

 

On June 30, 2024 a total of $445,379 of interest was accrued and settled to equity payable for the issuance of 1,093,267 shares of common stock.

 

On June 30, 2024 a total of $20,617 of interest was accrued and settled to equity payable for the issuance of 50,609 shares of common stock.

 

On September 30, 2024 a total of $225,136 of interest was accrued and settled to equity payable for the issuance of 964,593 shares of common stock.

 

On September 30, 2024 a total of $10,422 of interest was accrued and settled to equity payable for the issuance of 44,653 shares of common stock.

 

During the nine months ended September 30, 2024 2,516,394 shares were issued for $1,355,081 from equity payable and $235,558 equity payable was recorded.

 

As of the nine months ended September 30, 2024 we had an equity payable balance of $336,420.

 

13

 

Stock-based Plans

 

Stock Option Activity

 

The following table summarizes stock option activity for the nine months ended September 30, 2024.

 

    Options    

Weighted

Average

Exercise

Price

   

Weighted

Average

Remaining

Contractual

Term (Years)

 
Outstanding at December 31, 2022     6,691,216     $ 1.19       5.86  
Granted     2,678,500     $        
Exercised         $        
Forfeited/canceled     (329,893 )   $        
Expired     (1,742,468 )   $ 0.90       7.28  
Outstanding at December 31, 2023     7,297,355     $        
Granted     260,000     $        
Exercised         $        
Forfeited/canceled     (949,520 )   $        
Expired     (2,163,335 )   $        
Outstanding at September 30, 2024     4,444,500     $ 0.92       7.72  

 

2023

 

On May 11, 2023 the Company granted three employees 295,000 options to purchase shares of the Company’s common stock at the closing price as of May 11, 2023 of $0.98 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until May 16, 2033. The total estimated value using the Black-Scholes Model, based on a volatility rate of 75.76% and an option fair value of $0.705183 was $208,029.

 

On July 14, 2023 the Company granted one employees 1,000,000 options to purchase shares of the Company’s common stock at the closing price as of July 14, 2023 of $0.85 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until July 14, 2033. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.55% and an option fair value of $0.5590 was $605,383.

 

On July 17, 2023 the Company granted one employees 700,000 options to purchase shares of the Company’s common stock at the closing price as of July 17, 2023 of $0.79 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until July 17, 2033. The total estimated value using the Black-Scholes Model, based on a volatility rate of 74.57% and an option fair value of $0.5713 was $396,441.

 

On August 25, 2023 he Company granted four employees 650,000 options to purchase shares of the Company’s common stock at the closing price as of August 25, 2023 of $0.65 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until August 25, 2033. The total estimated value using the Black-Scholes Model, based on a volatility rate of 64.81% and an option fair value of $0.4257 was $285,773.

 

2024

 

On April 1, 2024, the Company granted two employees 250,000 options to purchase shares of the Company’s common stock at the closing price as of April 1, 2024 of $0.502 per share. The option shares will vest 25% on the first anniversary of the grant, then equally in 36 monthly installments thereafter, and are exercisable until April 1, 2034. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.63% and an option fair value of $0.212377 was $53,094.

 

On August 14, 2024, the Company granted one employee 10,000 options to purchase shares of the Company’s common stock at the closing price as of August 14, 2024 of $0.502 per share. The option shares will vest 25% immediately, then equally in 36 monthly installments thereafter, and are exercisable until August 14, 2034. The total estimated value using the Black-Scholes Model, based on a volatility rate of 73.63% and an option fair value of $0.0724 was $724.

 

14

 

Stock-Based Compensation Expense from Stock Options and Warrants

 

The impact on our results of operations of recording stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 were as follows:

 

    2024     2023     2024     2023  
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2024     2023     2024     2023  
General and administrative   $ 3,261     $ 62,599     $ (35,842 )   $ 181,382  
Sales and marketing     105,100       108,348       301,245       248,790  
Engineering, research, and development     40,429       46,830       127,461       119,334  
Total   $ 148,790     $ 217,777     $ 392,864     $ 549,506  

 

Valuation Assumptions

 

The fair value of each stock option award was calculated on the date of the grant using the Black-Scholes option pricing model. The following weighted average assumptions were used for the nine months ended September 30, 2024 and 2023.

 

    Nine Months Ended  
    September 30,  
    2024     2023  
Risk-free interest rate     4.69 %     3.99 %
Expected life (years)     7.00       7.50  
Expected dividend yield     %     %
Expected volatility     73.63 %     73.47 %

 

The risk-free interest rate assumption is based upon published interest rates appropriate for the expected life of our employee stock options.

 

The expected life of the stock options represents the weighted-average period that the stock options are expected to remain outstanding and was determined based on the historical experience of similar awards, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as influenced by changes to the terms of the Company’s stock-based awards.

 

The dividend yield assumption is based on our history of not paying dividends and no future expectations of dividend payouts.

 

The expected volatility in 2024 and 2023 is based on the historical publicly traded price of our common stock.

 

Restricted stock units

 

The following table summarizes restricted stock unit activity under our stock-based plans for the year ended December 31, 2023 and for the nine months ended September 30, 2024:

 

    Shares  
Outstanding at December 31, 2022     1,929,933  
Awarded     414,104  
Released     (545,012 )
Canceled/forfeited/expired      
Outstanding at December 31, 2023     1,799,025  
Awarded     715,205  
Released      
Canceled/forfeited/expired      
Outstanding at September 30, 2024     2,514,230  
         
Expected to vest at September 30, 2024     2,514,230  
Vested at September 30, 2024     2,514,230  
Unvested at September 30, 2024      
Unrecognized expense at September 30, 2024   $  

 

15

 

2023

 

On March 31, 2023, the Company granted four independent directors a total of 61,342 restricted stock units. The units were valued at $65,002 or $1.05 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) March 31, 2026, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

On June 30, 2023, the Company granted four independent directors a total of 80,160 restricted stock units. The units were valued at $65,003 or $0.81 per share, based on the closing stock price on the date of the grant. All units vest immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) June 30, 2026, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

On September 30, 2023, the company granted four independent directors a total of 101,564 restricted stock units. The units were valued at $65,001 or $0.64 per share, based on the closing stock price on the date of the grant. All units vest immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) September 30,2026, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

In the nine months ended September 30, 2023 the Company recorded $195,006 in restricted stock expense as board compensation.

 

2024

 

On March 31, 2024 the company granted five independent directors a total of 162,500 restricted stock units. The units were valued at $81,250 or $.50 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) March 31, 2026, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

On June 30,2024 the company granted five independent directors a total of 187,210 restricted stock units. The units were valued at $81,249 or $.434 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) June 30, 2026, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

On September 30, 2024 the company granted five independent directors a total of 365,495 restricted stock units. The units were valued at $81,250 or $.222 per share, based on the closing stock price on the date of the grant. All units vested immediately. The shares of common stock associated with the restricted stock units will be issued to each director upon the earliest to occur of (A) September 30, 2026, (B) a change in control of the Company, and (C) the termination of the director’s service with the Company.

 

In the nine months ended September 30, 2024, the Company recorded $243,749 in restricted stock expense as board compensation.

 

Stock Based Compensation from Restricted Stock

 

The impact on our results of operations of recording stock-based compensation expense for restricted stock units for the three and nine months ended September 30, 2024 and 2023 was as follows:

 

    2024     2023     2024     2023  
    Three Months Ended     Nine Months Ended  
    September 30,     September 30,  
    2024     2023     2024     2023  
General and administrative   $ 81,250     $ 65,001     $ 243,749     $ 195,006  
Total   $ 81,250     $ 65,001     $ 243,749     $ 195,006  

 

As of September 30, 2024, there was no unearned restricted stock unit compensation.

 

Warrants

 

The following table summarizes investor warrants as of September 30, 2024 and the years ended December 31, 2023 and 2022:

 

    Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (Years)  
Outstanding at December 31, 2022     6,147,898     $ 1.45       2.27  
Granted     9,563,787     $        
Exercised     (5,548,463 )   $        
Canceled/forfeited/expired         $        
Outstanding at December 31, 2023     10,163,222     $ 0.94       2.48  
Granted     8,916,660     $        
Exercised         $        
Canceled/forfeited/expired         $        
Outstanding at September 30, 2024     19,079,882     $ 0.77       2.13  

 

16

 

2023

 

During March 2023, 15 warrant holders exercised their common stock purchase warrant for 3,587,487 shares at the exercise price of $1.00 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders’ 3,921,952 new warrants to purchase common stock at $2.00 per share over a three-year period expiring in February 2025. The Company recorded $577,000 of stock-based expense related to warrants issued during the warrant conversion offer on February 14, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on a volatility rate of 63% and an option fair value of $0.3216.

 

During August and September of 2023, 18 warrant holders exercised their common stock purchase warrant for 1,906,976 shares at the exercise price of $.82 per share, resulting in additional capital of $3,557,487. As an inducement for the holder’s exercise of the warrants, we issued the holders’ 1,793,745 new warrants to purchase common stock at $.82 per share over a three-year period expiring between August and September 2026. The Company recorded $1,146,047 of stock-based expense related to warrants issued during the warrant conversion offer on September 6, 2023. The total estimated value of the warrants using the Black-Scholes Model is based on an average volatility rate of 72% and an option fair value of $0.2922.

 

2024

 

During the first quarter of 2024, one warrant holders was issued 3,291,664 warrants as an inducement for Convertible Notes issued at the exercise price of $.60 per share, resulting in additional capital of $2,250,000. The Company recorded $466,594 of stock-based expense related to warrants issued with issuance of convertible notes. The total estimated value of the warrants using the Black-Scholes Model is based on an average volatility rate of 93% and an option fair value of $0.1418.

 

During the second quarter of 2024, one warrant holders was issued 3,499,997 warrants as an inducement for Convertible Notes issued at the exercise price of $.60 per share, resulting in additional capital of $2,100,000. The Company recorded $371,242 of stock-based expense related to warrants issued with issuance of convertible notes. The total estimated value of the warrants using the Black-Scholes Model is based on an average volatility rate of 91% and an option fair value of $0.1768.

 

During the third quarter of 2024, one warrant holders was issued 2,124,999 warrants as an inducement for Convertible Notes issued at the exercise price of $.60 per share, resulting in additional capital of $1,275,000. The Company recorded $176,219 of stock-based expense related to warrants issued with issuance of convertible notes. The total estimated value of the warrants using the Black-Scholes Model is based on an average volatility rate of 104% and an option fair value of $0.1403.

 

9. Fair Value Measurements

 

Fair value is defined as an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the authoritative guidance establishes a three-tier value hierarchy, which prioritizes the inputs used in measuring fair value as follows: (Level 1) observable inputs such as quoted prices in active markets; (Level 2) inputs other than the quoted prices in active markets that are observable either directly or indirectly; and (Level 3) unobservable inputs in which there is little or no market data, which requires us to develop our own assumptions. This hierarchy requires companies to use observable market data, when available, and to minimize the use of unobservable inputs when determining fair value. On a recurring basis, we measure certain financial assets and liabilities at fair value.

 

The following table presents assets that are measured and recognized at fair value as of September 30, 2024 on a recurring and non-recurring basis:

 

Description   Level 1     Level 2     Level 3     Gains (Losses)  
Goodwill (non-recurring)   $     $     $     $  
Intangibles, net (non-recurring)   $     $     $ 57,589     $  

 

The following table presents assets that are measured and recognized at fair value as of December 31, 2023 on a recurring and non-recurring basis:

 

Description   Level 1     Level 2     Level 3     Gains (Losses)  
Goodwill (non-recurring)   $     $     $     $  
Intangibles, net (non-recurring)   $     $     $ 65,916     $  

 

10. Commitments and Contingencies

 

Litigation

 

Marina Soliman v. Subway Franchisee Advertising Fund Trust, LTD, Second Circuit Court of Appeals, Case No. 22-1726 – this is putative class action alleging that Defendant initiated telephone solicitations through text messages in violation of the Telephone Consumer Protection Act, 47 U.S.C § 227 et al. (“TCPA”). The district court granted Defendant’s motion to dismiss. The matter has been under submission with the Court since October 24, 2023. In the event that the Court reverses and remands the matter, the Company intends to seek an individual settlement of the matter, and if one cannot be reached, the Company intends to vigorously defend the matter.

 

Ruhi Reimer vs. Checkers Drive-In Restaurants, Inc. - JAMS Ref No. 5410000618 – this is a single Claimant arbitration action filed against Mobivity’s business partner alleging that text messages were sent to the consumer in violation of the TCPA’s regulations relating to the National Do Not Call Registry. The parties are beginning discovery at this time and a Merits Hearing has been set for January 14, 2025. Based on our current understanding, we believe that the case is pretextual and was set up in advance by the Claimant and his attorneys. Because discovery has only just started, it is premature to assess whether there is any material risk of an adverse award.

 

Abboud v. Circle K Stores Case – United States District Court, Dist. Arizona, Case No 2:23-cv-01683-DWL – this is a putative TCPA class action alleging that Mobivity and its business partner initiated text messages in violation of the TCPA’s regulations relating to the National Do Not Call Registry. We believe that plaintiff has sued the wrong defendant and that the client’s other servicer is actually responsible for any text messages that were sent to the putative class. We are actively attempting to persuade Plaintiff’s counsel to drop Mobivity from the suit.

 

17

 

Operating Lease

 

As of September 30, 2024, we have an operating lease asset balance for this lease of $600,624 and an operating lease liability balance for this lease of $731,764 recorded in accordance with ASC 842.

 

11. Related Party Transactions

 

Secured Promissory Notes

 

On June 30, 2021, we entered into a Credit Facility Agreement with Thomas Akin, one of the Company’s directors (the “Lender”). The Credit Facility Agreement was amended on November 11, 2022 to allow the Company to borrow up to $6,000,000. The Credit Facility Agreement was amended again on January 31, 2023 to extend the maturity of the agreement and related convertible notes thereunder until December 1, 2025. Principal payments have been deferred to a period beginning on January 1, 2024 and ending December 1, 2025.

 

As of September 30, 2024, the Company had drawn a total of $5,873,125, with a debt discount of $201,087 for a net principal balance of $5,672,038 and has equity payable balance $336,417.

 

Unsecured Promissory Note

 

On July 1, 2021, we entered into UP Notes in the aggregate principal amount of $271,875 with Talkot Fund, LP and investor in the Company. Each UP Note bears interest on the unpaid balance at the rate of fifteen percent (15%) per annum and the principal and accrued interest are due and payable no later than December 31, 2023.

 

As of September 30, 2024, the Company had an outstanding principal balance of $271,875, an equity payable balance of $20,122 of accrued interest.

 

Convertible Notes

 

During first quarter of 2024, the Company issued 8 Convertible Notes payable to related parties for $1,950,000. As an inducement we issued 3,249,997 warrants to purchase shares of our common stock at $.60 per share. Simple interest on the unpaid principal balance of this Note will accrue at the rate of 8.0% per annum. Accrual of interest will commence on the date of this Note, will continue until this Note is fully paid, and will be payable in a single installment at maturity three years from the date the Convertible Note was issued.

 

During the second quarter of 2024 the Company 8 Convertible Notes payable to related parties for $2,100,000. As an inducement we issued 3,499,997 warrants to purchase shares of our common stock at $.60 per share. Simple interest on the unpaid principal balance of this Note will accrue at the rate of 8.0% per annum. Accrual of interest will commence on the date of this Note, will continue until this Note is fully paid, and will be payable in a single installment at maturity three years from the date the Convertible Note was issued.

 

During the third quarter of 2024 the Company issued 4 Convertible Notes payable to related parties for $1,275,000. As an inducement we issued 2,124,999 warrants to purchase shares of our common stock at $.60 per share. Simple interest on the unpaid principal balance of this Note will accrue at the rate of 8.0% per annum. Accrual of interest will commence on the date of this Note, will continue until this Note is fully paid, and will be payable in a single installment at maturity three years from the date the Convertible Note was issued.

 

As of September 30, 2024 the Convertible Notes issued to related parties had a principal balance of $7,325,000 with a debt discount of $